Purchase Order 75N93024P00085
Award Date
12/16/23
Potential Completion Date
12/15/24
Potential Value
$48K
Federal Agency
National Institute of Allergy and Infectious Diseases
Awardee
Illumina, Inc.
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20814, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services' National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $36,117 firm fixed price purchase order to Illumina, Inc. to provide a NEXTSEQ 1000 SILVER SUPPORT PLAN. The place of performance is Potomac, Maryland and the period of performance is from December 1, 2023 through November 30, 2024. This support plan is likely associated with the NIH's ongoing genomic sequencing and bioinformatics research efforts to...
The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), awarded a $53,029.50 firm-fixed price purchase order to Illumina, Inc. for a one-year service plan covering preventative maintenance, full parts and labor coverage, reagent replacement, remote technical support, and software/hardware updates for the agency's Illumina NextSeq 2000 sequencing equipment at their Laboratory of Viral Diseases. This purchase was made under full and...
The Department of Health and Human Services' National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $15,575 purchase order to Illumina, Inc. for the annual renewal of a MiSeq Silver support plan. The contract will provide ongoing service and support for Illumina's MiSeq sequencing systems located at the NIH in Bethesda, Maryland, from January 5, 2024 through January 4, 2025. As the largest funder of biomedical research in the world, the NIH and NIAID...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm-fixed-price purchase order to Illumina, Inc. for a NEXTSEQ 2000 SILVER SUPPORT PLAN. The potential value of the contract is $48,209.00, with a completion date of April 2, 2025. This contract is not set aside and is for the provision of sequencing and array-based solutions to support genomic analysis and life science research. Illumina, a for-profit...
The Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) awarded a firm fixed price purchase order to Illumina, Inc., a for-profit manufacturer of genomic sequencing systems and reagents. The $101,340.96 contract provides a one-year service plan for Illumina's NextSeq and MiSeq sequencing platforms, as well as an iSeq 100 system, to be used at an NIAID facility in Frederick, Maryland. The contract was...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $21,171 firm fixed price purchase order to Illumina, Inc. for the annual renewal of the NextSeq bronze support plan. As a manufacturer and provider of sequencing and array-based solutions, Illumina will deliver maintenance services for the NextSeq sequencing system located in Rockville, Maryland under this contract. No set-aside provision was utilized for this...
The National Institutes of Health's National Institute of Allergy and Infectious Diseases (NIH NIAID) awarded a $213,150 firm fixed price purchase order to Illumina, Inc. to deliver a NextSeq 1000 Sequencing System. The award was made under simplified acquisition procedures solicitation number RFQ-NIH-NIAID-2183146, which sought quotes for the sequencing system as well as its delivery to NIH in Bethesda, Maryland, installation, setup, operator training, and maintenance/support services. The...
The Department of Health and Human Services' National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $207,415 firm fixed price purchase order to Illumina, Inc. of San Diego, California. Under the terms of the contract, Illumina will provide one NEXTSEQ 2000 sequencing system to support NIH's research efforts in the areas of allergy and infectious disease. Place of performance is Illumina's facilities in San Diego. The period of performance is from...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm fixed price purchase order to Illumina, Inc. for a NextSeq 2000 Sequencing System or equal, valued at $239,700.00. The requirement was issued through a commercial items solicitation using Simplified Acquisition Procedures, with no set-aside designation. The sequencing system is intended to support the increased workload at the Center for Human Immunology,...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $39,337 firm fixed price purchase order to Illumina, Inc. of San Diego, California. The order is for a NextSEQ service agreement from July 1, 2023 to June 30, 2024. The solicitation was a notice of intent to negotiate on a sole source basis with Illumina for priority service and partnership for their manufactured NextSEQ sequencers. As priority status is...